Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence.
作者信息
Asai Nobuhiro, Ohkuni Yoshihiro, Shoji Kazufusa, Kaneko Norihiro
出版信息
J Bras Pneumol. 2013 Mar-Apr;39(2):242-4. doi: 10.1590/s1806-37132013000200017.
Abstract
摘要
相似文献
1
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在评估肺癌复发中的效能
J Bras Pneumol. 2013 Mar-Apr;39(2):242-4. doi: 10.1590/s1806-37132013000200017.
2
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对无症状非小细胞肺癌患者的术后随访很有用。
Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):859-64. doi: 10.1093/icvts/ivs368. Epub 2012 Aug 21.
3
Lung cancer: positron emission tomography/computed tomography and the new staging system.肺癌：正电子发射断层扫描/计算机断层扫描与新分期系统
Semin Roentgenol. 2013 Oct;48(4):308-22. doi: 10.1053/j.ro.2013.05.001.
4
The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.18F 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在食管癌中的价值。
Cancer Imaging. 2011 Oct 3;11 Spec No A(1A):S156-60. doi: 10.1102/1470-7330.2011.9040.
5
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的基于体积的参数可改善 1 至 3 个阳性腋窝淋巴结的乳腺癌根治术后患者的疾病复发预测。
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):738-46. doi: 10.1016/j.ijrobp.2013.08.001. Epub 2013 Sep 21.
6
[18F-FDG-PET-CT in soft tissue sarcomas: when to image?].[18F-FDG-PET-CT在软组织肉瘤中的应用：何时进行成像？]
Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):43-9. doi: 10.1016/j.remn.2013.07.005. Epub 2013 Oct 2.
7
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).复发性胰腺癌和胆管癌：18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（PET/CT）
Abdom Imaging. 2011 Aug;36(4):463-71. doi: 10.1007/s00261-011-9729-6.
8
Recurrence of lung cancer after radiofrequency ablation detected by PET/CT and contrast enhanced CT scan.通过PET/CT和增强CT扫描检测到的射频消融术后肺癌复发。
Med Health R I. 2012 May;95(5):146-8.
9
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.F18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在非小细胞肺癌潜在根治性手术后患者中的临床价值：241例患者的经验
Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.
10
Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对结直肠癌患者管理的影响
PET Clin. 2015 Jul;10(3):345-60. doi: 10.1016/j.cpet.2015.03.007. Epub 2015 Apr 18.
引用本文的文献
1
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review.新辅助放化疗或化疗后手术在ⅢA期（N2）非小细胞肺癌中优于单纯根治性放化疗或放疗：一项荟萃分析和系统评价。
Onco Targets Ther. 2016 Feb 22;9:845-53. doi: 10.2147/OTT.S95511. eCollection 2016.
2
Magnetic resonance imaging of the chest in the evaluation of cancer patients: state of the art.胸部磁共振成像在癌症患者评估中的应用：现状
Radiol Bras. 2015 Jan-Feb;48(1):33-42. doi: 10.1590/0100-3984.2013.1794.
本文引用的文献
1
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?立体定向体部放疗（SBRT）治疗可手术的 I 期非小细胞肺癌：SBRT 能否与手术相媲美？
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751. Epub 2010 Jul 16.
2
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.两种立体定向体部放射分割方案治疗医学上无法手术的Ⅰ期非小细胞肺癌的比较：克利夫兰诊所的经验
J Thorac Oncol. 2009 Aug;4(8):976-82. doi: 10.1097/JTO.0b013e3181adf509.
3
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.年龄和合并症作为非小细胞肺癌治疗中的独立预后因素：加拿大国立癌症研究所临床试验组试验综述
J Clin Oncol. 2008 Jan 1;26(1):54-9. doi: 10.1200/JCO.2007.12.8322.
4
Lung cancer in octogenarians: factors affecting long-term survival following resection.八旬老人的肺癌：影响切除术后长期生存的因素
Eur J Cardiothorac Surg. 2007 Aug;32(2):370-4. doi: 10.1016/j.ejcts.2007.04.002. Epub 2007 Jun 6.
5
Lobectomy for treating bronchial carcinoma: analysis of comorbidities and their impact on postoperative morbidity and mortality.肺叶切除术治疗支气管癌：合并症分析及其对术后发病率和死亡率的影响。
J Bras Pneumol. 2006 Nov-Dec;32(6):495-504. doi: 10.1590/s1806-37132006000600005.
6
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.18F-氟代脱氧葡萄糖正电子发射断层扫描在非小细胞肺癌分期中的成本效益：PLUS研究
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1444-9. doi: 10.1007/s00259-003-1199-9. Epub 2003 May 29.
7
Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.慢性阻塞性肺疾病（COPD）对非小细胞肺癌（NSCLC）手术患者肺部并发症及长期生存的影响。
Lung Cancer. 2002 Jul;37(1):95-101. doi: 10.1016/s0169-5002(02)00014-4.
8
9
A new international staging system for lung cancer.一种新的肺癌国际分期系统。
Chest. 1986 Apr;89(4 Suppl):225S-233S. doi: 10.1378/chest.89.4_supplement.225s.
10
Prognosis and survival in resected lung carcinoma based on the new international staging system.基于新国际分期系统的切除性肺癌的预后与生存情况
J Thorac Cardiovasc Surg. 1988 Sep;96(3):440-7.
Zotero 插件